If the five-year data on the Scott Hart reported in 2018 showed that the use of CTA in addition to standard care resulted in more correct diagnosis of coronary artery disease than standard care alone, then is it time we lowered the threshold for referring patients for CTA?

09 CTA Study Points at Benefits of Wider Use

Dr. Bernard Monteleone, former Head of Cardiology at St. Francis Hospital in New York, gives an informed analysis of highly-anticipated trials and whether or not their findings could impact clinical practice guidelines and reduce the risk of cardiovascular disease.

Share 09 CTA Study Points at Benefits of Wider Use

Sign up to save your podcasts

09 CTA Study Points at Benefits of Wider Use

09 CTA Study Points at Benefits of Wider Use